Weekly CFO Sells Highllight: Facebook Inc, Vertex Pharmaceuticals Inc, Nike Inc.

Author's Avatar
Oct 06, 2014

According to GuruFocus Insider Data, the recent CFO sales were: Facebook Inc, Vertex Pharmaceuticals Inc, Nike Inc.

Facebook Inc. (FB, Financial): David M Wehner sold 11,533 Shares

On 08/20/2014, CFO David M Wehner sold 11,533 shares at an average price of $74.96. The price of the stock has increased by 3.5% since. Facebook Inc. has a market cap of $201.35 billion and its shares were traded at around $77.58. The company has a P/E ratio of 84.10 and P/S ratio of 19.99.

Facebook Inc. announced their 2014 second quarter results with revenues of $2.91 billion and gross profit of $2.44 billion; the net income was $788 million. The 2013 total revenue was $7.87 billion, a 55% increase from the 2012 total revenue. The 2013 gross profit was $6 billion, a 61% increase from the 2012 gross profit. The 2013 net income was $1.5 billion.

On 10/02/2014, COO Sheryl Sandberg sold 283,334 shares at an average price of $76.81. The price of the stock has increased by 1% since. On 10/01/2014, Chief Product Officer Christopher K Cox sold 5,934 shares at an average price of $77.12. The price of the stock has increased by 0.6% since. On 09/22/2014, Chief Technology Officer Michael Todd Schroepher sold 35,000 shares at an average price of $77. The price of the stock has increased by 0.75% since.

Vertex Pharmaceuticals Inc. (VRTX, Financial): EVP & CFO Ian F Smith sold 108,026 Shares

On 09/30/2014, EVP & CFO Ian F Smith sold 108,026 Shares at an average price of $112.68. The price of the stock has decreased by 4.7% since. Vertex Pharmaceuticals Inc. has a market cap of $25.85 billion and its shares were traded at around $107.38. The company has a P/S ratio of 29.99.

Vertex Pharmaceuticals Inc. announced their 2014 second quarter results with revenues of $138.4 million and gross profit of $121.1 million; the net income was $159.4 million. The 2013 total revenue was $1.21 billion, a 21% decrease from the 2012 total revenue. The 2013 gross profit was $1.1 billion, a 13% decrease from the 2012 gross profit. The 2013 net income was $445 million.

On 09/30/2014, CEO and President Jeffrey M Leiden sold 200,000 shares at an average price of $112.69. The price of the stock has decreased by 4.71% since. On 10/01/2014, EVP\Chief Commercial Officer Stuart A Arbuckle sold 12,417 shares at an average price of $107.71. The price of the stock has decreased by 0.31% since. On 10/01/2014, Director Elaine Ullian sold 5,000 shares at an average price of $107.74. The price of the stock has decreased by 0.33% since.

Nike Inc. (NKE, Financial): EVP & CFO Donald W Blair sold 132,000 Shares

On 09/26/2014, EVP and CFO Donald W Blair sold 132,000 shares at an average price of $88.49. The price of the stock has increased by 1.83% since. Nike Inc. has a market cap of $78.4 billion and its shares were traded at around $90.11. The company has a P/E ratio of 30.10 and P/S ratio of 2.93 with a dividend yield of 1.06%. Over the past 10 years, Nike Inc. had an annual average earnings growth of 9.40%. GuruFocus rated Nike Inc. the business predictability rank of 4.5-star.

Nike Inc. announced their 2014 second quarter results with revenues of $7.4 billion and gross profit of $3.4 billion; the net income was $691 million. The 2014 total revenue was $27.8 billion, a 10% increase from the 2013 total revenue. The 2014 gross profit was $12.45 billion, a 13% increase from the 2013 gross profit. The 2014 net income was $2.7 billion.

On 09/30/2014, Director Orin Smith sold 16,000 shares at an average price of $88.71. The price of the stock has increased by 1.58% since. On 09/30/2014, EVP, Global Sports Marketing John F Slusher sold 34,206 shares at an average price of $88.75. The price of the stock has increased by 1.53% since. On 09/26/2014, COO Eric D Sprunk sold 66,000 shares at an average price of $88.03. The price of the stock has increased by 2.36% since.